Modular Medical, Inc. (NASDAQ: MODD)

Modular Medical, Inc. is a pre-revenue medical device company focused on the design, development, and commercialization of innovative insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company seeks to fundamentally alter the trade-offs between cost and complexity and access to higher standards of care by creating an innovative two-part patch pump. Its goal is to simplify and streamline the user experience from initial patient introduction to prescription assistance, insurance reimbursement, training, and day-to-day use with strong clinical support, thereby expanding the wearable insulin delivery device market beyond highly motivated super users to the mass market.

The company generates revenue through the sale of its insulin pump products and associated consumables. Its primary products include the MODD1 insulin pump and its successor, the Pivot, a tubeless version of the MODD1 designed for improved cost, usability, and manufacturability. Revenue is expected to come from both the reusable pump unit and disposable cartridges that hold insulin, with cartridge sales providing recurring revenue. The company targets patients with type 1 and type 2 diabetes requiring multiple daily insulin doses, particularly the segment referred to as 'Almost Pumpers' who are aware of pump benefits but face barriers due to cost, complexity, and usability.

The company operates through the following segments:

• Insulin Pump Systems: This segment encompasses the design, development, manufacturing, and commercialization of insulin pump products, including the MODD1 and Pivot devices. The segment focuses on creating a two-part patch pump system that integrates reusable electronics with disposable insulin cartridges and infusion sets. It includes efforts to obtain regulatory clearances such as FDA 510(k) submissions and CE mark approvals for U. S. and European markets. The segment also involves partnerships with manufacturing collaborators like Phillips Medisize to scale production and ensure compliance with quality system regulations.

Modular Medical, Inc. positions itself as an innovator in the insulin pump market by addressing key limitations of existing products such as complexity, cost, and cumbersome design. The company differentiates itself through a proprietary pumping mechanism that enables a reusable system, reducing long-term costs compared to competitors that discard electronics every few days. Its products offer advantages such as a slimmer profile, lighter weight, no external controller, no charging requirements, and a simple one-button interface. The company aims to capture share from established players like Medtronic, Tandem Diabetes Care, and Insulet by appealing to underserved patient segments seeking affordable, easy-to-use insulin delivery solutions.

The company serves patients with type 1 and type 2 diabetes who require multiple daily insulin doses, particularly those identified as 'Almost Pumpers' who are interested in pump therapy but deterred by current product shortcomings. These customers include individuals managing diabetes through multiple daily injections who seek improved glycemic control but face barriers related to cost, complexity, and ease of use. Modular Medical, Inc. also targets healthcare providers such as endocrinologists, diabetes educators, and primary care physicians who prescribe insulin therapy and influence patient adoption of new technologies.